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Abstract
Background: Approximately 40% of mammalian mRNA sequences contain AUG trinucleotides
upstream of the main coding sequence, with a quarter of these AUGs demarcating open reading
frames of 20 or more codons. In order to investigate whether these open reading frames may
encode functional peptides, we have carried out a comparative genomic analysis of human and
mouse mRNA 'untranslated regions' using sequences from the RefSeq mRNA sequence database.
Results: We have identified over 200 upstream open reading frames which are strongly conserved
between the human and mouse genomes. Consensus sequences associated with efficient initiation
of translation are overrepresented at the AUG trinucleotides of these upstream open reading
frames, while comparative analysis of their DNA and putative peptide sequences shows evidence
of purifying selection.
Conclusion: The occurrence of a large number of conserved upstream open reading frames, in
association with features consistent with protein translation, strongly suggests evolutionary
maintenance of the coding sequence and indicates probable functional expression of the peptides
encoded within these upstream open reading frames.
Background
The 5' untranslated regions (5' UTRs) of vertebrate
mRNAs typically vary from a few tens of bases up to sev-
eral hundred bases in length, and contain a variety of fea-
tures which affect the efficiency of translation of the main
coding sequence (CDS) of the transcript. These include
the length and secondary structure of the 5' UTR, the
sequence context of the initiation codon of the main CDS
and the presence of upstream AUG codons (uAUGs). The
original scanning model of mRNA translation (reviewed
in [1]) postulates that the translating ribosome enters the
mRNA at the 5' end and processes linearly down the mol-
ecule until reaching the first AUG, at which point transla-
tion is initiated. Further work has since resulted in
refinements to this model, such as the recognition of leaky
scanning, where uAUGs in a sequence context which var-
ies from the optimal consensus for initiation of transla-
tion are bypassed by the ribosome complex, and of
reinitiation, where the ribosome resumes scanning after
translation of upstream open reading frames (uORFs)
(reviewed in [2]).
Both the leaky scanning and ribosome reinitiation mech-
anisms typically result in a decrease in efficiency of trans-
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lation from subsequent initiation codons, in some cases
virtually eliminating translation of the main CDS,
although more usually causing between two and 50-fold
reduction in protein levels [3-8]. It has therefore been pro-
posed that the presence of uAUGs may represent a
method of post-transcriptional regulation, through
repression of translation from the main AUG. This theory
is supported by the identification of transcriptional and
splice variants with an identical main CDS but with 5'
UTRs containing varying numbers of uAUGs [6,9,10], as
well as cases of an uAUG repressing translation in one tis-
sue type while not affecting it in another [11,12].
Furthermore a number of diseases have been associated
with uAUGs. These are caused either through mutations
introducing or eliminating uAUGs, resulting in a conse-
quent decrease or increase in translation efficiency [13-
16], or by physiological changes which may affect the
degree of repression by a particular uAUG [17] or may
change splicing patterns of the 5' UTR to alter the number
of uAUGs [6].
In addition to repression of translation by uAUGs, addi-
tional regulation of mRNAs containing uORFs can be
brought about by the uORF affecting transcript stability.
The premature termination codon model for nonsense-
mediated decay (NMD) of mRNA (reviewed in [18-20])
suggests that transcripts containing uORFs would effec-
tively have a premature termination codon at the end of
the uORF. Translation of the uORF would reduce progres-
sion of the ribosome to the main CDS and ultimately to
its termination codon, and therefore may result in
increased targetting of these molecules for NMD, thereby
reducing the steady-state level of that particular transcript.
Some uORFs do appear to have such a role in destabiliza-
tion of their mRNA by promoting NMD [21-23] while
others have been shown to similarly destabilize mRNA,
but via an NMD-independent pathway [24].
Despite the examples above, most studies on the effects of
uAUGs have considered the role of the uAUG as acting
solely as an alternative site of ribosome initiation and
therefore to repress translation of the main CDS; the role
of the associated uORF is apparently considered largely
incidental. Even in reports describing the function of the
uORF itself, the role of the translated peptide is primarily
a cis-acting one, either causing ribosome stalling at the ter-
mination codon of the uORF and a high level of repres-
sion of the main CDS [25,26] or, more occasionally,
affecting mRNA stability. In this report we describe our
identification of a substantial number of uORF-encoded
peptides (uPEPs) which are highly evolutionarily con-
served and which we propose have functions beyond that
of simply reducing translation of the main CDS.
Results
Presence of uAUGs and uORFs
For this experiment, we restricted our analysis to uORFs of
20 to 99 codons in length. While these specific values are
somewhat arbitrary, we chose them to maximise the prob-
ability that the uORFs chosen for further analysis were
genuine and not affected by sequencing errors or cloning
artefacts. While it is possible that a uORF of less than 20
codons could encode a functional peptide, ORFs longer
than this are potentially easier to identify as conserved
between species and furthermore would be more amena-
ble to subsequent experimental validation. We chose the
upper limit after our initial results indicated that only a
small fraction of uORFs (~5%) were more than 100
codons long, so their exclusion was unlikely to greatly
bias the analysis, while their inclusion would lead to the
potential for contamination of our results by artefacts
such as co-ligated cDNA clones or misidentification of the
main CDS in a cDNA clone.
In the RefSeq release 6 database, there are 21768 human
and 17106 mouse mature mRNA sequences. Of these,
Table 1: Frequency of upstream AUGs and ORFs.
Human Mouse
Number of mRNA sequences in initial dataset (1) 16504 11291
Number of mRNA sequences containing > 1 uAUG (2) 9531 6352
Total number of uAUGs (3) 35599 24308
Number of mRNA sequences containing > 1 uORF (4) 4557 2820
Total number of uORFs (5) 8216 5487
Number of mRNA sequences containing > 1 uORF after removal of duplicates (6) 3924 2795
Total number of uORFs after removal of duplicates (7) 7138 5430
Number of mRNA sequences containing > 1 uORF after removal of blast matches (8) 3650 2678
Total number of uORFs after removal of blast matches (9) 6454 5089
Frequency of upstream AUGs and ORFs in human and mouse RefSeq mRNA sequences. Initial dataset refers to all sequences of > 60 nucleotides 
annotated as 5' UTRs. Numbers in parentheses indicate the corresponding stage in the filtering flowchart (figure 1).BMC Genomics 2006, 7:16 http://www.biomedcentral.com/1471-2164/7/16
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approximately 75% and 66% respectively have an anno-
tated 5' UTR of 60 bases or more in length (exact figures
given in table 1). The difference in the proportion of long
5' UTRs is primarily because of a much higher number of
mouse sequences containing only the main CDS, with no
5' UTR given (11% of mouse sequences, compared with
only 4.5% of human ones). Of the population of mRNAs
with long 5' UTRs (>60 bases), approximately 55% have
at least one uAUG, with about 25% having one or more
uORFs (average about 1.9 uORFs). We only considered
uORFs which had a stop codon either within the 5' UTR
or no more than 30 bases (ten codons) into the main CDS
since uORFs that extend into the main coding region may
potentially be conserved as a side-effect of selection of the
main open reading frame, rather than by any specific
selection on their own peptide products. By limiting the
reading frame overlap to less than half of the minimum
length of the uORFs being investigated in this study, we
hoped to minimise any biasing effect caused by this mech-
anism.
The human dataset has approximately 15% redundancy
among uORF sequences, in contrast to only around 1% in
the mouse; this may be a result of a lack of depth of the
mouse mRNA resource, since these duplicates seem to
mostly be the result of splice variants with similar or iden-
tical 5' UTRs. This is supported by the redundancy of gene
name annotation of the two datasets, which is 3.7% for
mouse but 16.9% for the human sequences.
Our final filter was to remove any uPEPs with homology
to known proteins, since our preliminary results had indi-
cated that a considerable number of RefSeq entries
appeared to have frameshift mutations or introduced stop
codons within the main CDS, which had led to internal
ATG codons being described as the start of the CDS. This
results in a 5' truncation of the annotated main CDS, the
starting section of which will then appear to form a uORF
in the 5' UTR. By using a relatively stringent filter, we
removed approximately 10% of the uPEPs which showed
more than a small degree of similarity to proteins in the
NCBI non-redundant peptide sequence database, thus
minimising the possibility that the uORFs are in fact part
of a main CDS, and appear to be in the 5' UTR as a conse-
quence of incorrect annotation. This filter also resulted in
only novel sequences being further characterised. Of
course, it is possible that uPEPs resulting from such
sequencing and annotation errors would still pass our fil-
tering process if they represented previously unidentified
variants of the main reading frame, but in view of the
depth of the existing protein databases, we believe that
this would affect relatively few sequences.
An equivalent filtering process was applied to ORFs iden-
tified in the 3' UTRs. Since 3' UTRs are typically longer
than 5' ones, we found approximately 30% more 3' UTRs
that were longer than 60 bases, totalling four times more
sequence data than the 5' UTR set. These 3' UTRs con-
tained ten times as many AUGs and ORFs as were
observed in 5' UTRs. However the proportions of down-
stream open reading frames (dORFs) which were filtered
out because of duplication or matching to an entry in the
nr protein database were similar to those of uORFs. The
results of the full filtering process are summarised in
tables 1 and 2 (for 5' UTRs and 3' UTRs respectively).
Although 40–50% of mRNAs have at least one uAUG
codon, this percentage is in fact much lower than would
be expected either by chance or by comparison with the
frequency of other upstream codons (~90% of mRNAs in
this dataset), supporting the theory that there is signifi-
cant selection against AUG codons in 5' UTRs [27,28]. In
contrast, the 3' regions of the mRNAs which we have
tested contain AUGs at approximately the level expected
by chance based on the sequence composition and length.
This absence of selection against downstream AUG
Table 2: Frequency of downstream AUGs and ORFs.
Human Mouse
Number of mRNA sequences in initial dataset (1) 21597 14790
Number of mRNA sequences containing > 1 dAUG (2) 19853 14327
Total number of dAUGs (3) 352301 229945
Number of mRNA sequences containing > 1 dORF (4) 16965 11598
Total number of dORFs (5) 85876 55815
Number of mRNA sequences containing > 1 dORF after removal of duplicates (6) 14252 11377
Total number of dORFs after removal of duplicates (7) 69202 54403
Number of mRNA sequences containing > 1 dORF after removal of blast matches (8) 13899 11299
Total number of dORFs after removal of blast matches (9) 65258 52786
Frequency of downstream AUGs and ORFs (dAUGs and dORFs) in human and mouse RefSeq mRNA sequences. Initial dataset refers to all 
sequences of > 60 nucleotides annotated as 3' UTRs. Numbers in parentheses indicate the corresponding stage in the filtering flowchart (figure 1).BMC Genomics 2006, 7:16 http://www.biomedcentral.com/1471-2164/7/16
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codons, in combination with the generally accepted view
that ORFs in the 3' UTR are not translated, supports our
use of the 3' UTR as a valid negative control data set.
Conservation between species
From the 6454 human and 5089 mouse uPEPs which
passed all our filtering processes, we identified 204
homologous pairs (defining homologs as uPEPs with a
blastp E value of < 0.01, identity of > 50%, aligned start
and stop codons and no insertions or deletions) [see
Additional files 1, 2]. The proportion of uPEPs with
homologs was therefore approximately 3.5%, in compar-
ison to less than 1% of peptide translations of dORFs
under the same conditions (500 pairs from 65258 human
and 52786 mouse dORFs), showing that uPEPs are more
highly conserved than non-translated downstream
sequences.
A HomoloGene cluster was identified for both the human
and mouse transcript sequences for 177 of the uPEP pairs.
In 169 of these cases (95%), both transcripts mapped to
the same cluster; therefore the vast majority of the identi-
fied pairs appear to be genuine orthologs. This was also
the case for the downstream pairs, of which just less than
90% are orthologous.
We identified 79 human/mouse homolog uORF pairs
where both human and mouse sequences matched entries
in the EST database with an aligned start codon. In total
these matched 241 unique EST sequences, mostly from
cow (Bos taurus) and pig (Sus scrofa), of which 201 (82%)
also contained a stop codon aligned with that of the
mouse and human uORFs. Of the 40 without an aligned
stop codon, 15 had one at an adjacent codon, and a fur-
ther 16 had a stop codon within 5 codons of the human
homolog (compared with ~4 and ~7 which would be
expected if stop codons were randomly distributed within
this region of the 5' UTR). This overrepresentation of in-
frame stop codons is a consistent with there being selec-
tive pressure to maintain the length of these uORFs. In
contrast, 72% of the ESTs matching to dORFs had an
aligned stop codon, while of the remainder, the observed
number having a stop codon within five codons (155)
was almost exactly that predicted by random assignment
of stop codons (154).
Strength of AUG context
The efficiency of initiation of translation from a given
AUG codon is determined in part by the local sequence
context. The most efficient context is known as the Kozak
sequence (GCCA/GCCAUGG), and two positions within
this sequence, -3 and +4 (the A of the AUG codon is des-
ignated +1) are the most critical for determining the
strength of the initiator and hence translation efficiency
[29,30]. AUGs matching the consensus at both of these
Flowchart of steps used in identification of conserved  upstream and downstream ORFs Figure 1
Flowchart of steps used in identification of conserved 
upstream and downstream ORFs. Numbers in parentheses 
indicate the corresponding count in tables 1 and 2.
RefSeq mRNA sequences
Human and mouse
Blastp peptides vs nr protein Db
Match human to mouse peptides
Blastp, E-value < 0.01
Translate ORFs to peptide
Confirm homolog pairs 
Aligned AUG, >50% identity, same length
Identify UTRs > 60 bases
# UTRS (1)
# UTRs with AUG (2)
# individual AUGs (3)
Identify ORFs
AUG, 20-99 codons, stop codon
in UTR or early CDS
# UTRs with ORF (4)
# individual ORFs (5)
Remove duplicate ORFs
# UTRs with unique ORF (6)
# individual unique ORFs (7)
Remove peptides with match
E-value < 0.01
# UTRs with novel peptide (8)
# individual novel peptides (9)BMC Genomics 2006, 7:16 http://www.biomedcentral.com/1471-2164/7/16
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sites are described as being in an optimal context, those
matching at one are strong, and those matching neither
are described as weak.
The proportions of AUG in each context are given in table
3 (expressed as a percentage of all AUGs in that category).
Among the conserved uORFs, the proportion with an
optimal AUG context is almost double that observed for
other classes of uORF (figure 2). While this is still lower
than is observed for the main coding region AUGs, it is a
strong trend and one not observed in the downstream
controls, where conserved ORFs have no noticeable
enrichment for optimal AUG context.
Interestingly the proportion of optimal AUGs among the
main CDSs of mRNAs with one or more uORFs is substan-
tially lower than for mRNAs without a uORF (33.2% c.f.
41.3%). This is not the case for dORFs, where the propor-
tion of optimal and strong main AUGs is unaffected by
the presence or absence of a dORF.
Synonymous mutation rates
We joined each of the 204 human and mouse DNA uORF
sequences sequentially to create two aligned composite
sequences. This alignment of 17766 bases was used to cal-
culate a ratio of synonymous to non-synonymous nucle-
otide substitutions using the SNAP.pl program [31-33].
This ratio was 1.65, while the artificially-generated control
dataset gave a mean of 0.99 (ranging from 0.70 to 1.36
over 10,000 trials). The ratio of the adjacent control
sequences was 1.12 for upstream and 1.11 for down-
stream sequence.
Insertion of one or two nucleotides at the beginning of
each composite uORF sequence causes SNAP.pl to calcu-
late the ratio for the two alternative reading frames. Syn-
onymous mutations are mostly in the third nucleotide
position of each codon, while substitution of either of the
other two nucleotides generally causes non-synonymous
changes. Consequently calculations using such frame-
shifted sequences typically give lower ratios of synony-
mous to non-synonymous substitutions. This was the case
for the composite uORF sequence, with ratios of 1.37 and
1.14 respectively in the +1 and +2 reading frames, and
confirms that the relatively high proportion of synony-
mous substitutions is related to codon position and is not
an artefact of nucleotide bias or specific mutation types.
Based on the distribution of the artificially-mutated con-
trol data set, the probability of achieving a synonymous to
non-synonymous ratio of 1.65 with codon-neutral evolu-
tion is less than 10-10. This is true even assuming a back-
ground level of 1.12 (the observed value of the adjacent
control sequence) rather than the theoretical 0.99. The
composite ratio for dORFs produced a ratio of 1.29, still
significantly above the expected value for neutral muta-
tion but at a much lower level than the uORFs (p < 0.01).
This value also showed a much smaller change for the two
alternate reading frames (1.22 for both), suggesting that it
may be a consequence of the sequence composition and
not codon dependent.
An alternative explanation for the high ratio value of the
dORF sequences is that it is an artefact of the selection
procedures used, namely that of choosing ORFs conserved
Proportion of AUG codons in optimal, strong or weak sequence contexts for main coding regions, interspecific conserved  uORFs, and non-conserved uORFs Figure 2
Proportion of AUG codons in optimal, strong or weak sequence contexts for main coding regions, interspecific conserved 
uORFs, and non-conserved uORFs.
Main CDS Conserved uORF Non-conserved uORF
Optimal
Strong
WeakBMC Genomics 2006, 7:16 http://www.biomedcentral.com/1471-2164/7/16
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at a peptide level. In this case, it provides a reference of the
background level from which the uORF composite
sequence is still highly significantly different (p < 10-5).
For this analysis of synonymous and non-synonymous
changes, we used a single composite sequence from each
organism rather than performing the analysis individually
for each ORF. This allows us to compensate for the varying
lengths of the ORFs while not affecting the overall
number of synonymous and non-synonymous changes
(because all the sequences remain in their original reading
frame). Furthermore, since many of the ORF sequences
are short (282 sequences are shorter than 100 nucle-
otides) and have relatively few changes, a single mutation
can have a disproportionately large effect if testing the
sequences individually; the use of a single long sequence
reduces the impact of these outliers.
Discussion
It is clear from our analyses and those of other studies
[27,28,34-36] that a large proportion of mRNAs, probably
between 40% and 50%, contain at least one upstream
AUG codon, and that several thousand of these may
potentially encode peptides of 20 or more amino acid res-
idues. Indeed, in a recent study, Pesole and colleagues
[27] found similar frequencies of uAUGs and uORFs to
those reported here, using human, mouse and rat RefSeq
mRNA sequences. However, probably due to differences
in methodology, they identified fewer conserved uORFs,
but they predicted that these would have biological activ-
ity.
To date the majority of characterised uORFs appear to
function as cis-acting regulatory elements which inhibit
initiation levels at the main AUG codon [3-8]. While this
suggests that the phenomenon of uAUG-mediated repres-
sion is a common mechanism for post-translational regu-
lation, we believe that the results of our identification and
analysis of conserved uORFs indicates that a sub-category
of uORFs may have more varied biological functions than
simple repression of translation of a main coding
sequence. We base this conclusion on our observations
that uORFs conserved between human and mice show a
range of features consistent with selection at the peptide
level which are much less apparent among non-conserved
uORFs.
Firstly, although the 3' UTR tends to be more conserved
between species than the 5' region [37-39], we find nearly
a four-fold higher proportion of human uORFs have a
mouse ortholog than do dORFs. Secondly, the initial AUG
codons of these conserved uORFs are much more likely to
match both of the critical consensus sites for ribosome
initiation than are non-conserved uORFs or control
dORFs. The correlation between sequence conservation
and selection for translation-enhancing AUG contexts in
these specific ORFs is consistent with our hypothesis that
they are likely to encode biologically relevant peptides.
Thirdly, while most orthologous uORFs have both start
and stop codons positionally conserved, those that do
not, have a stop codon present within five codons and in
frame nearly three times more frequently than would be
expected by chance. This conservation in uORF length,
which is not seen in the dORF control set, would be
expected for short functional peptides, where even a few
additional residues represents a proportionally large
change in peptide size and structure. Finally there is a very
significant mutational bias of uORFs in favour of synony-
Table 3: Comparison of the frequency of AUGs in different contexts.
Context of AUG present in: Human Mouse
Optimal Strong Weak Optimal Strong Weak
All main CDS 39.8 51.4 8.8 38.7 52.6 8.6
Conserved uORFs 24.5 44.6 30.9 24.0 42.6 30.4
Non-conserved uORFs 16.5 48.8 34.7 17.1 47.5 35.3
Main CDS of uORF genes 33.6 52.4 13.9 32.7 53.7 13.6
Short uORFs 12.3 51.2 36.5 12.6 50.0 37.4
Theoretical uAUG* 15.4 50.4 34.2 14.8 50.2 34.9
Conserved dORFS 11.8 47.4 40.8 11.0 45.2 40.8
Non-conserved dORFs 11.4 49.0 39.6 12.0 48.0 40.1
Main CDS of dORF genes 39.2 51.6 9.2 38.7 52.7 8.5
Short dORFs 8.5 48.6 42.9 8.9 47.9 43.2
Theoretical dAUG* 10.6 49.7 39.7 10.6 49.6 39.6
Comparison of the frequency of AUGs in different contexts between uORFs and main ORFs. All values are expressed as percentages of the total 
number of AUGs in that class of ORF.
*Theoretical is defined as the predicted distribution of AUG contexts if the nucleotide selection at the two critical positions was randomly selected 
based on the sequence composition of all UTRs in that category (i.e. 5' UTR composition for upstream AUGs, 3' UTR composition for downstream 
AUGs).BMC Genomics 2006, 7:16 http://www.biomedcentral.com/1471-2164/7/16
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mous substitutions, indicating selection at the peptide,
rather than the nucleotide, level.
One argument against peptides encoded by uORFs having
significant biological activity is the typical instability and
rapid degradation of small peptides [8,40]. This argument
maintains that uPEPs would not survive long enough to
elicit measurable biological activity. In addition, uPEPs
may not be synthesized at high enough levels to be func-
tionally relevant, either because of low translation effi-
ciencies or because their encoding uORFs are only present
in rare transcript variants. However, translated uPEPs have
been identified in human cells by mass spectrometry [41]
and recently trans activity has been demonstrated for at
least two small peptides in mammals, a 43 residue natu-
rally occurring uPEP [42] and a recombinant 15 residue
peptide [43]. Interestingly, in the former case, biological
activity was found even though the peptide itself could
not be detected. It is therefore clear that, although uORF-
encoded peptides may exist at only very low levels within
the cell, they still have the potential for trans-acting bio-
logical functions. These trans-acting functions remain to
be elucidated, but uPEPs have the same characteristics as
other intracellular peptides which have been predicted to
regulate a host of protein-protein, RNA-protein and DNA-
protein interactions [44].
In conclusion, we have carried out a genome-wide com-
parative analysis of human and mouse uORFs, and have
identified a number of well conserved uORFs which show
evidence of evolutionary selection at a peptide level.
While previous analyses have implicated a small number
of uPEPs in cis-acting post-transcription regulation, we
believe that the presence of hundreds of uORFs, which are
strongly conserved at the peptide level, suggests other bio-
logical roles for uPEPs.
Methods
Data sets
We used RefSeq release 6 human and mouse mRNA
sequences from NCBI [45], taking only entries with an
NM-prefixed accession number (i.e. those derived from
mature mRNA sequences). We used the annotation pro-
vided within the GenBank format file to identify the start
of the main CDS for each entry where this could be unam-
biguously identified; sequences where the CDS start point
was not absolutely defined (i.e. anything not containing a
line of the format 'CDS 123..567', where 123 and 567 are
the start and end coordinates of the main CDS) were
excluded from further analysis, as were sequences with
short 5' UTRs (<60 bases). Based on the annotated CDS
start points, we retrieved sequence from the beginning of
the entries to 30 nucleotides past the annotated start of
the main CDS.
For a control comparison, we also extracted 3' untrans-
lated regions (3' UTRs) from the human and mouse Ref-
Seq database. We identified stop coordinates of the main
CDS as described above and, providing the 3' UTR was
longer than 60 bases, we retrieved sequence from imme-
diately after the stop codon to the end of the entry.
Identification of uORFs
We screened the retrieved UTR sequences for the presence
of ORFs of 20 to 99 codons in length starting with an AUG
codon and terminating with a stop codon. Only uORFs
with a stop codon within the 5' UTR or less than 30 bases
into the main CDS were analysed further. Similarly, 3'
control ORFs were required to have both a start and stop
codon within the 3' UTR.
Although the RefSeq database is a non-redundant
resource and contains no duplicate sequences, a consider-
able proportion of the ORFs which we identified were
duplicated. This was mostly because more than one tran-
script variant shared the same ORF or ORFs. In these cases,
we retained a single representative of each sequence,
removing any other ORFs with an identical translated
peptide sequence.
To minimise the possibility that the ORFs are in fact part
of a main CDS, and appear to be in the UTR as a conse-
quence of incorrect annotation, we performed a NCBI
blastp alignment (E value cutoff of 0.01) with the peptide
translation of all our identified ORF sequences against the
NCBI nr protein database, and only continued analysis
with ORFs which did not give any hits.
Identification of conserved and orthologs ORFs
To identify ORFs conserved between human and mouse,
we performed an NCBI blastp alignment of peptide trans-
lations of the mouse ORF sets against the equivalent
human set using an E value cut off of 0.01, equivalent to
that used in elimination of main coding sequence con-
tamination. We screened matches identified from this
search for ORFs where the initial methionine from both
sequences was aligned, the peptides were the same length
with homology extending along the whole length, and the
overall identity between the two sequences was > 50%.
Although aligned start codons and identical length are not
necessarily features of conserved sequences, this require-
ment provides us with a subset of the most reliable
homologous ORFs; it also simplifies the alignments
required for calculation of synonymous and non-synony-
mous mutation rates.
We used the accession numbers of the original mRNA
sequences for each of these human/mouse ORF pairs to
search HomoloGene (NCBI). The pairs were consideredBMC Genomics 2006, 7:16 http://www.biomedcentral.com/1471-2164/7/16
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to be orthologous if both mapped to the same Homolo-
Gene identifier.
For each mouse/human ORF pair identified as described
above, we used tblastn (peptide sequence against a trans-
lated DNA database) of peptide translations of both the
mouse and human ORFs against the NCBI non-mouse,
non-human EST database (E value cut off of 1.0) to iden-
tify potential uORF and dORF sequences from other spe-
cies. Matches to rodent and primate species were
discounted, as were matches where the initial AUG codon
did not align with the reference sequence.
A flowchart summarising the full screening process, from
RefSeq datasets through to conserved ortholog pairs, is
shown in figure 1.
Strength of Kozak consensus
For all ORFs we evaluated the strength of the initiation
codon based on the presence of specific nucleotides in the
Kozak consensus sequence [29,30]. The two most critical
nucleotide positions in determining the efficiency of initi-
ation at a given AUG codon are A/G-3 and G+4 [29,30]. We
therefore assigned an arbitrary 'strength score' to each
AUG codon corresponding to how many of these critical
nucleotides matched the consensus; either zero, one or
two. We calculated the relative proportions of optimal
(score of two), good (score of one) and weak (score of
zero) for all ORF AUG and main AUG codons, as well as
AUG codons of short ORFs (five codons or less) and the-
oretical predictions based on local nucleotide usage. The-
oretical predictions were calculated as follows; optimal:
((pG + pA) × (pG)), weak: ((pC + pT) × (1 - pG)), good: (1 -
(optimal + weak)), where pN was the proportion of that
nucleotide in all long (>60 bases) UTRs from that species.
Calculation of synonymous/non-synonymous mutation 
rates
To calculate an overall ratio of synonymous to non-syn-
onymous changes across all conserved ORFs without bias-
ing for sequence length, we created a single composite
sequence for each species. We concatenated the total col-
lection of conserved human and mouse ORFs, excluding
the initial AUG and stop codon from each ORF, to gener-
ate two aligned composite ORFs. This alignment was ana-
lysed using the SNAP.pl program [31-33], which
calculates the number of synonymous mutations as a pro-
portion of possible synonymous mutations, and similarly
for non-synonymous mutations, and returns a ratio of
these two values. Deviations of this ratio away from one
are indicative of positive or negative selective pressure on
the peptides encoded by the DNA sequences.
We generated reference data by taking duplicate copies of
the human composite sequence and computationally
mutating the second copy at random using mutation rates
of 5–20% (approximately that observed between the real
sequences). The choice of replacement nucleotides was
biased in accordance with the base content of the compos-
ite ORF. We used SNAP.pl to calculate the synonymous/
non-synonymous mutation rate for the generated test
sequences, and performed 10,000 repeats of this muta-
genesis/ratio calculation approach to model the distribu-
tion of ratios generated by 'neutral' mutations.
To compensate for the possibility of our synonymous
mutation rate calculations being affected by the overall
level of sequence conservation between human and
mouse, or by specific features of 5' and 3' UTR sequences,
we used sequences immediately adjacent to, and of the
same length as, the ORFs to generate additional control
data. For the upstream ORFs, preceding sequence was
retrieved, while for the downstream control ORFs, subse-
quent sequence was used (in this way, all control
sequences were further away from the main coding region
than the ORF, ensuring that none overlapped into this
region). We created composite sequences for these con-
trols and calculated synonymous/non-synonymous
mutation rates as described above. We also calculated per-
centage sequence identities between the composite adja-
cent sequence alignments as well as between the
composite ORF alignments.
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uAUG, upstream AUG codon; ORF, open reading frame;
uORF, upstream open reading frame; dORF, downstream
open reading frame; CDS, coding sequence; 5' UTR, five
prime untranslated region; 3' UTR, three prime untrans-
lated region; uPEP, upstream peptide.
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